Saturnino (Nino) Fanlo Joins Human Longevity As Chief Financial Officer

SAN DIEGO, May 25, 2017 /PRNewswire/ -- Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, announced today that Saturnino (Nino) Fanlo will be joining the company as Chief Financial Officer, reporting to CEO Cynthia Collins. Fanlo brings decades of financial services acumen and strategic leadership to the role at HLI and will be instrumental in helping guide the company as it expands and strengthens commercialization and operations.

Human Longevity, Inc. (PRNewsFoto/Human Longevity, Inc.)

"Nino's 30 years of financial services leadership especially his success in the fintech arena make him the ideal CFO for HLI," said Collins. "Our company is poised for commercial success and I'm eager to have Nino as a key member of the team to ensure we remain laser focused on our goal of creating health intelligence in the healthcare market."

"Joining Cindy, Craig Venter and the rest of the strong management team at HLI is a genuine honor. The technologies and products that HLI has created to positively impact the healthcare landscape are remarkable and the chance to contribute my skills and experience to this company is an exhilarating challenge," said Fanlo.

Fanlo joins HLI from Social Finance, Inc. (Sofi), the largest and fastest growing online lender, where he served as President and Chief Financial Officer. Fanlo was a key leader at Sofi who worked hand in hand with the CEO and founder to design and build capital markets, loan sale, finance, and credit and loan operations there. He led five successful capital raises for more than $1.9 billion and moved the company from an $8 million to a $4.3 billion valuation in under five years. He was also a key architect of many of Sofi's unique financial products.

Prior to Sofi Fanlo held a series of high level leadership roles in well-respected financial services firms. Before Sofi, he was a Senior Advisor at Golden Gate Capital where he helped to develop their $1 billion Credit Opportunity Fund and the $200 million Public Equity Fund. For 5 years, he served as the CEO of KKR Financial and CIO and Partner of KKR Asset Management where was responsible for capital raising, investment policy, portfolio selection and management, recruiting and development, and investor communications. He led the initial public offering of KKR Financial after just nine months of establishing this spinout. He also raised $4 billion in equity capital and $10 billion of permanent investment capital. 

Prior to that he also served as Executive Vice President and Treasurer of Wells Fargo & Co., where he was responsible for funding, capital and investment portfolio including cash management and liquidity operations. Other roles in his career include leadership positions with Goldman, Sachs & Co., Australian Capital Equity, and First Boston Corporation.

Fanlo received his Bachelor of Economics from Haverford College, Haverford, PA.

About Human Longevity, Inc
Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI's business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. For more information, please visit or


To view the original version on PR Newswire, visit:

SOURCE Human Longevity, Inc.

Back to news